Karin Towers, PH.D. Psychologist - Forensic Medicare: Not Enrolled in Medicare Practice Location: 215 Main Street, Brockton District Court, Adult Court Clinic, Brockton, MA 02301 Phone: 617-504-0101 |
Dr. Judith Ann Bayog, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 940 Belmont St, Brockton, MA 02301 Phone: 508-583-4500 |
Timothy James O'farrell, PH.D. Psychologist - Family Medicare: Not Enrolled in Medicare Practice Location: 940 Belmont St, Vamc - 116b1, Brockton, MA 02301 Phone: 508-583-4500 Fax: 774-826-1087 |
Dr. Stephen Charles Bonsignore-berry, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 209 Quincy St, Brockton, MA 02302 Phone: 508-584-2291 Fax: 508-584-3480 |
Shavon Franks Psychologist - Family Medicare: Not Enrolled in Medicare Practice Location: 30 Downey Rd, Brockton, MA 02302 Phone: 857-243-4845 |
Dr. Kate Louise Martin Hinrichs, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 940 Belmont St, Va Boston Hcs; (gec-181), Brockton, MA 02301 Phone: 774-826-3451 Fax: 774-826-2643 |
Guenite Romain Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 10 Meadowbrook Rd, Brockton, MA 02301 Phone: 508-742-4400 |
Dr. Sebastian James Bliss, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 940 Belmont St Bldg 5, Brockton, MA 02301 Phone: 774-826-3510 |
News Archive
Genticel, a French biotechnology company and leading developer of therapeutic vaccines, today announces that it has licensed its Vaxiclase technology to Serum Institute of India Ltd., for use as a component in acellular multivalent combination vaccines including pertussis antigens.
The 30-ton, superconducting magnet that forms the center of a 7-Tesla MRI (magnetic resonance imaging) system developed by Siemens Medical Solutions will be uncrated and moved by crane from a truck into the New York University School of Medicine's Center for Biomedical Imaging this Friday morning.
Interim study results from STARTversoTM 4 presented today at CROI+ show that 80 percent of hepatitis C (HCV) patients also infected with HIV achieved early treatment success with faldaprevir (BI 201335) combined with pegylated interferon and ribavirin (PegIFN/RBV).
The drug flibanserin, which was originally created as an antidepressant, is effective in treating women with low libido, pooled results from three separate clinical trials have found.
› Verified 8 days ago